Mars announces new leadership for its Veterinary Health and Science Diagnostics businesses

The company has a strong presence in the US, Europe, and Asia, with a wide range of products and services for pets and their owners.

The New Leadership at Mars Veterinary Health

Mars Veterinary Health is a leading global company in the pet care industry, with a rich history spanning almost 90 years. Recently, Nefertiti Greene has been announced as the new Global President of Mars Veterinary Health, marking a significant milestone in the company’s journey.

Nefertiti Greene: A New Era for Mars Veterinary Health

Nefertiti Greene is a seasoned executive with extensive experience in the pet care industry.

Nef Greene Brings Industry Expertise to Mars, Inc.

Nef Greene’s Background and Experience

Nef Greene brings a wealth of experience to Mars, Inc., with a career spanning nearly three decades in the services and healthcare industries. His extensive background includes stints at prominent companies such as Johnson & Johnson, Bayer, and Forest Laboratories. Greene’s experience in these organizations has equipped him with a deep understanding of the pharmaceutical industry and its complexities. Key highlights of Greene’s experience include:

Over 25 years of experience in the pharmaceutical industry

Leadership roles in various companies, including Johnson & Johnson and Forest Laboratories

Expertise in services and healthcare, with a focus on pharmaceuticals and diagnostics

The Creation of the Science & Diagnostics Division

In 2022, Mars, Inc. created a new division, Science & Diagnostics, with Nef Greene at the helm. This division is focused on developing innovative solutions for the pharmaceutical industry, leveraging Mars’ expertise in confectionery and other areas. Greene’s leadership will be instrumental in driving the growth and success of this new division.

Pharmaceutical Executive Brings Decades of Experience to Mars, Inc.

Katie Devine’s Background and Experience

Katie Devine brings a wealth of experience to her new role at Mars, Inc. Her background in the pharmaceutical industry spans over two decades, with a focus on leadership and innovation. Prior to joining J&J, she held various leadership positions at Pfizer and Merck, where she developed and implemented strategies to drive growth and improve patient outcomes. Key highlights of her experience include:

Served as President of U.S. General Medicines, Canada & Puerto Rico at J&J

Held leadership positions at Pfizer and Merck

Developed and implemented strategies to drive growth and improve patient outcomes

The Science & Diagnostics Division at Mars

The Science & Diagnostics division at Mars is a key area of focus for the company, with a focus on developing innovative solutions for the healthcare industry. The division is responsible for creating and commercializing new products and technologies that address unmet medical needs. Key areas of focus for the Science & Diagnostics division include:

Developing innovative solutions for the healthcare industry

Creating and commercializing new products and technologies

Addressing unmet medical needs

Katie Devine’s Leadership Style and Vision

Katie Devine is known for her leadership style, which emphasizes collaboration, innovation, and a customer-centric approach.

A New Era for Mars’ Science & Diagnostics Division

Katie Devine’s appointment as the head of Mars’ Science & Diagnostics division marks a significant milestone in the company’s history. With over two decades of experience working for Mars, Devine is well-equipped to lead the division and drive innovation.

Key Highlights of Katie Devine’s Appointment

20+ years of experience: Devine has spent over two decades working for Mars, gaining a deep understanding of the company’s values and mission. Leadership skills: As the head of the Science & Diagnostics division, Devine will be responsible for leading a team of experts in their field. Innovation and growth: Devine is committed to driving innovation and growth within the division, ensuring that Mars remains at the forefront of scientific research and diagnostics.

We are committed to making a positive impact on the pet care industry and the environment.

Our Purpose

At Mars, we are driven by a clear purpose: A BETTER WORLD FOR PETS. This purpose is at the heart of everything we do, from the way we develop our products to the way we interact with our customers and the wider community. Our purpose is not just a slogan, but a guiding principle that shapes our decisions and actions.

Our Commitment to Pet Care

We are passionate about delivering the best possible care for pets. We believe that every pet deserves the highest quality food, and we work tirelessly to develop products that meet their unique needs. Our range of brands, including Royal Canin, Pedigree, Whiskas, and M&M’s, offer a variety of options to suit different lifestyles and preferences. Nutrition and Health: We are committed to providing pets with the nutrients they need to thrive. Our products are formulated to meet the specific needs of different life stages, breeds, and health conditions. Quality and Safety: We take pride in the quality and safety of our products. We use only the finest ingredients and adhere to strict quality control measures to ensure that our products meet the highest standards. * Sustainability: We are dedicated to reducing our environmental impact. We use sustainable ingredients, minimize waste, and promote eco-friendly practices throughout our operations.**

Our Impact

At Mars, we are proud of the positive impact we have on the pet care industry and the environment. We believe that our products and practices make a real difference in the lives of pets and their owners.

For more information about Mars, please visit www.mars.com. Join us on Facebook, Twitter, Instagram, LinkedIn and YouTube. Photo – https://mma.prnewswire.com/media/2532395/Mars_Inc.jpg SOURCE Mars Inc